Skip to content
HighOnCity Ottawa
NEWS

Ottawa says a freezer failure cost $2M in emergency drugs; a $20M loss in 2024 also hit the stockpile

Health Canada says a mechanical failure exposed part of one stockpiled drug treatment to unsafe temperatures. The agency will not disclose what was lost.

· 3 min read · HOC Ottawa Desk
Ottawa says a freezer failure cost $2M in emergency drugs; a $20M loss in 2024 also hit the stockpile
File photo: Javier Balseiro / Pexels
★ FREE NEWSLETTER
Get the best of Ottawa–Gatineau in your inbox

The day's top stories, food & events — every morning at 7. Unsubscribe anytime.

The Public Health Agency of Canada says a mechanical failure in one of its freezers cost $2 million in emergency drugs. A small portion of a drug treatment held in the national emergency stockpile had to be thrown out, Health Canada spokesperson Hélène-Annie Lavoie said.

The treatment is used to respond to a biological threat. The agency says the loss did not compromise Canada's ability to respond to that threat, because the stockpile still held another treatment for it.

Lavoie said an internal investigation was opened immediately, the cause was found, and new measures are in place. The agency will not say what was lost or how much. Lavoie said disclosure would "expose sensitive operational details about how Canada prepares for and responds to chemical, biological, radiological, nuclear or other public health threats."

The stockpile is a network of warehouses that stores medical supplies, vaccines and emergency response equipment. It was set up during the Cold War for nuclear emergencies and has since been used for SARS, COVID-19, natural disasters and bioterror attacks.

This is not the first loss. In December 2024, federal officials said an open freezer door cost $20 million in pharmaceuticals from the stockpile. In October, the Office of the Auditor General reported that the agency wrote off more than $331 million in expired or damaged medical supplies in 2025–26, a total its office says includes both freezer losses.

The auditor also found that more than $20 million in pharmaceuticals was discarded in 2025 because warehouse problems, including inadequate temperature monitoring, had been flagged in 2022 and 2023. Its staff told the public accounts committee the $20.4 million discard followed a freezer alarm that did not sound. Conservative health critic Ted Falk said in February he would seek a committee investigation into the 2024 loss.

The explanation for the 2024 loss has also shifted. In February it was given as an open freezer door, after it was first described as temperature fluctuations from several factors.

What we're still asking

Which drug treatment was lost, and how many doses were affected?

What did the internal investigation find beyond the cause, and will it be made public?

What happened to the warehouse freezer problems the auditor flagged in 2022 and 2023?

We'll update this story as answers emerge.